同花顺财经

麦格理资本:给予石药集团(01093.HK)“增持”评级 目标价25.39港元

2018-12-07 19:01:18      同花顺财经      

  麦格理资本12月6日发布公告。Even though today’s stock market reaction disagrees, we believe CSPC deserves a premium valuation among blue chips for having a defensible portfolio in the near term. We reiterate Outperform with a TP of HK$25.39.

以上资讯由同花顺AI写手完成,写作系统尚处于测试阶段,内容仅供参考。

21